Search for Articles
Jun 20, 2023
HAYA Therapeutics Adds Douglas L. Mann, M.D. as Chairperson of Clinical Advisory Board
Mar 14, 2023
Acesion Pharma Positive phase 2 data from Atrial Fibrillation clinical trial – primary endpoint met
Feb 27, 2023
Puzzle Medical Closes CAN$ 34 million Series A Funding Round to Complete Human Feasibility Study Led by Cordis-X
Feb 16, 2023
HAYA Therapeutics Adds World-Leading Cardiologist and Dark Genome Pioneer to Advisory Boards
Feb 9, 2023